Ascendis Pharma A/S vs Open Text Corporation — how do they compare? Ascendis Pharma A/S trades at $254.01 (market cap $16.67B), while Open Text Corporation trades at $23.89 (market cap $5.80B). The key difference: Ascendis Pharma A/S is far larger — about 2.9× Open Text Corporation's market cap, and Open Text Corporation pays a 4.67% dividend while Ascendis Pharma A/S pays none. Which is the better fit depends on your goals.
| ASND | OTEX | |
|---|---|---|
Market Cap | $16.67B | $5.80B |
Sector | Health | Technology |
52-Week High | $277.18 | $39.69 |
52-Week Low | $189.74 | $20.01 |
Enterprise Value | $17.04B | $10.81B |
Dividend Yield | — | 4.67% |
Trailing returns across standard periods
Latest headlines on both assets
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →Open Text Corporation is a global leader in Enterprise Information Management (EIM) software and solutions. The company provides a comprehensive platform that helps organizations manage, secure, and leverage their unstructured digital content, including documents, emails, and media files. OTEX's offerings span content management, business process management, customer experience management, and security, serving large enterprises across various industries worldwide.
Read more on OTEX →